Hyderabad Telangana, India

Dnyandeo Punde


Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Dnyandeo Punde in Pharmaceutical Patents

Introduction

Dnyandeo Punde is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of important compounds. With a total of two patents to his name, Punde's work has implications for drug development and therapeutic applications.

Latest Patents

Dnyandeo Punde's latest patents include a novel polymorph of an intermediate useful in the preparation of palbociclib. This polymorph exhibits enhanced properties that improve the processability of the intermediate and the synthesis of palbociclib. Additionally, he has developed novel crystalline forms of cabozantinib (S)-malate and cabozantinib free base. These forms, designated as form-M, M, Mand M, along with methods for their production, represent significant advancements in the field.

Career Highlights

Punde is currently associated with Mylan Laboratories Limited, where he continues to innovate and contribute to pharmaceutical research. His work is characterized by a focus on improving the efficacy and manufacturability of critical drug compounds.

Collaborations

Dnyandeo Punde collaborates with talented professionals in his field, including Ramakoteswara Rao Jetti and Anjaneyaraju Indukuri. These collaborations enhance the research and development efforts within his team.

Conclusion

Dnyandeo Punde's contributions to pharmaceutical innovations through his patents reflect his commitment to advancing drug synthesis and development. His work not only benefits the pharmaceutical industry but also has the potential to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…